Bruker Corp BRDR B2RK34

Morningstar Rating
R$30.84 +0.34 (1.11%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

B2RK34 is trading at a LOCK|gbYph premium.
Price
R$30.84
Fair Value
LOCK|.#>!Zw<
Uncertainty
LOCK|>b?d
1-Star Price
LOCK|.G&?k<L
5-Star Price
LOCK|.j%RhFr
Economic Moat
LOCK|V#>y
Capital Allocation
—

Trading Information

Previous Close Price
R$30.50
Day Range
R$30.84–30.84
52-Week Range
R$17.42–30.84
Bid/Ask
R$0.00 / R$0.00
Shares Outstanding
152.36M
Market Cap
R$4.70B
Volume/Avg
9 / 24

Key Statistics

Price/Earnings (Normalized)
3.16
Price/Sales
0.25
Dividend Yield (Trailing)
0.17%
Dividend Yield (Forward)
0.23%
Dividend Payment Schedule
Apr, Jul
Total Yield
0.17%

Company Profile

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
11,085

Valuation

Metric
B2RK34
Price/Earnings (Normalized)
3.16
Price/Book Value
0.38
Price/Sales
0.25
Price/Cash Flow
2.19
Price/Earnings
B2RK34

Financial Strength

Metric
B2RK34
Quick Ratio
0.83
Current Ratio
1.85
Interest Coverage
0.11
Quick Ratio
B2RK34

Profitability

Metric
B2RK34
Return on Assets (Normalized)
4.69%
Return on Equity (Normalized)
12.70%
Return on Invested Capital (Normalized)
7.24%
Return on Assets
B2RK34

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|N$%$&L<LOCK|g%M>v$172B
Medtronic PLC
MDT
LOCK|JGk?hwkLOCK|@>^<$113B
Stryker Corp
SYK
LOCK|fFlyLz<LOCK|>^k$106B
Boston Scientific Corp
BSX
LOCK|TnS%<&LOCK|py<&<$62B
Edwards Lifesciences Corp
EW
LOCK|F@>&%>@LOCK|%!#w$49B
DexCom Inc
DXCM
LOCK|b>t?J?$?LOCK|>%ZW$32B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|JL$>$>!LOCK|F#N$30B
Koninklijke Philips NV ADR
PHG
LOCK|b&zLOCK|F@T$24B
Steris PLC
STE
LOCK|m?TJ$wLOCK|<dWxd$21B
Zimmer Biomet Holdings Inc
ZBH
LOCK|#!Ml$jRLOCK|#s$17B

Sponsor Center